These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1173516)

  • 21. Postsynaptic dopamine/adenosine interaction: II. Postsynaptic dopamine agonism and adenosine antagonism of methylxanthines in short-term reserpinized mice.
    Ferré S; Herrera-Marschitz M; Grabowska-Andén M; Casas M; Ungerstedt U; Andén NE
    Eur J Pharmacol; 1991 Jan; 192(1):31-7. PubMed ID: 1828237
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modification of the caffeine-induced locomotor stimulation by a cholinergic mechanism.
    Waldeck B
    J Neural Transm; 1974; 35(3):197-205. PubMed ID: 4427109
    [No Abstract]   [Full Text] [Related]  

  • 23. The effect of bromocriptine on locomotor activity and cerebral catecholamines in rodents.
    Dolphin AC; Jenner P; Sawaya MC; Marsden CD; Testa B
    J Pharm Pharmacol; 1977 Dec; 29(12):727-34. PubMed ID: 22618
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of acute or chronic pentobarbital administration on the steady state levels and the turnover rates of catecholamines in discrete brain areas of mice.
    Nabeshima T; Fujimori K; Ho IK
    Prog Neuropsychopharmacol; 1981; 5(2):121-8. PubMed ID: 7267838
    [No Abstract]   [Full Text] [Related]  

  • 25. Mechanism of action of piribedil on noradrenergic neurons in rat brain.
    Bareggi SR; Markey K; Paoletti R
    Biochem Pharmacol; 1978; 27(24):2803-5. PubMed ID: 736975
    [No Abstract]   [Full Text] [Related]  

  • 26. The relative importance of dopamine and noradrenaline receptor stimulation for the restoration of motor activity in reserpine or alpha-methyl-p-tyrosine pre-treated mice.
    Dolphin AC; Jenner P; Marsden CD
    Pharmacol Biochem Behav; 1976 Jun; 4(6):661-70. PubMed ID: 981283
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Locomotor responses to benzodiazepines, barbiturates and ethanol in diazepam-sensitive (DS) and -resistant (DR) mice.
    Phillips TJ; Gallaher EJ
    Psychopharmacology (Berl); 1992; 107(1):125-31. PubMed ID: 1589560
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cataleptic action of nitrazepam and brain dopamine function in mice.
    Matsui Y; Deguchi T
    Neuropharmacology; 1977 Apr; 16(4):253-8. PubMed ID: 140329
    [No Abstract]   [Full Text] [Related]  

  • 29. Behavioral effects of alpha-methyltyrosine after prior depletion of brain catecholamines.
    Rech RH; Carr LA; Moore KE
    J Pharmacol Exp Ther; 1968 Apr; 160(2):326-35. PubMed ID: 5651375
    [No Abstract]   [Full Text] [Related]  

  • 30. Increased accumulation of ( 3 H) catecholamines formed from ( 3 H) dopa after treatment with caffeine and aminophylline.
    Waldeck B
    J Pharm Pharmacol; 1972 Aug; 24(8):654-5. PubMed ID: 4403749
    [No Abstract]   [Full Text] [Related]  

  • 31. Alteration of norepinephrine metabolism by barbiturates.
    Davis VE; Cashaw JL; McLaughlin BR; Hamlin TA
    Biochem Pharmacol; 1974 Jul; 23(13):1877-98. PubMed ID: 4156469
    [No Abstract]   [Full Text] [Related]  

  • 32. Action of dopamine receptor agonists in forebrain and hypothalamus: rotational behavior, ovulation, and dopamine turnover.
    Fuxe K; Agnati LF; Corrodi H; Everitt BJ; Hökfelt T; Löfström A; Ungerstedt U
    Adv Neurol; 1975; 9():223-42. PubMed ID: 1146654
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Depression of cerebellar cGMP by barbiturates. Relationship to locomotor activity.
    Morgan WW; Pfeil KA
    Neuropharmacology; 1984 Jul; 23(7A):773-7. PubMed ID: 6089023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in brain norepinephrine associated with sensitization to d-amphetamine.
    Short PH; Shuster L
    Psychopharmacology (Berl); 1976 Jul; 48(1):59-67. PubMed ID: 9657
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurochemical profile of EMD 45609 (carmoxirole), a dopamine DA2-receptor agonist.
    Haase AF; Greiner HE; Seyfried CA
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Jun; 343(6):588-94. PubMed ID: 1682817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Locomotor responses of FAST and SLOW mice to several alcohols and drugs of abuse.
    Phillips TJ; Burkhart-Kasch S; Gwiazdon CC; Crabbe JC
    Ann N Y Acad Sci; 1992 Jun; 654():499-501. PubMed ID: 1632613
    [No Abstract]   [Full Text] [Related]  

  • 37. Drug antagonism studied on frog flexor reflex and on mouse motility.
    Molinengo L; Orsetti M
    Pharmacology; 1983; 27(1):50-7. PubMed ID: 6611648
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological evidence for a stimulation of dopamine neurons by noradrenaline neurons in the brain.
    Andén N; Grabowska M
    Eur J Pharmacol; 1976 Oct; 39(2):275-82. PubMed ID: 185062
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differences between the effects of acute and long-term treatment with desmethylimipramine on reserpine-induced release of amines from rat brain.
    Roffler-Tarlov S
    Biochem Pharmacol; 1975 Jul; 24(13-14):1321-5. PubMed ID: 1148020
    [No Abstract]   [Full Text] [Related]  

  • 40. Withdrawal from repeated administration of a low dose of reserpine induced opposing adaptive changes in the noradrenaline and serotonin system function: a behavioral and neurochemical ex vivo and in vivo studies in the rat.
    Antkiewicz-Michaluk L; Wąsik A; Możdżeń E; Romańska I; Michaluk J
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Mar; 57():146-54. PubMed ID: 25445479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.